CashuNovartis AG's Strong Q4 Highlights Arrowhead Pharmaceuticals' Growth and Innovation in Biopharma8 days ago
CashuNovartis AG's Itvisma Gene Therapy Approved by FDA for Spinal Muscular Atrophy Treatment12 days ago